Next Financial Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,000
Closed -$6K 2840
2021
Q2
$6K Buy
+2,000
New +$6.33K ﹤0.01% 2174
2017
Q1
Sell
-500
Closed -$1K 2363
2016
Q4
$1K Hold
500
﹤0.01% 2334
2016
Q3
$1K Buy
+500
New +$768 ﹤0.01% 2327
2015
Q2
Sell
-200
Closed -$2K 1987
2015
Q1
$2K Hold
200
﹤0.01% 1725
2014
Q4
$3K Sell
200
-400
-67% -$5.82K ﹤0.01% 1674
2014
Q3
$8K Buy
+600
New +$7.14K ﹤0.01% 1891

Other funds holding INFI

Next Financial Group's INFI Position: Q3 2021 in Review

Next Financial Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2021, closing a stake of 2,000 shares — an estimated $6K sold.

Next Financial Group first reported a position in INFI in Q3 2014 and held it in 6 quarters. The position peaked at $8K in Q3 2014. 107 funds tracked by Wall St. Rank hold INFI as of Q3 2021.

  • Next Financial Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Next Financial Group sold 2,000 Infinity Pharmaceuticals, Inc. shares in Q3 2021, an estimated $6K.
  • Next Financial Group first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 6 quarters.
  • Next Financial Group's Infinity Pharmaceuticals, Inc. position peaked at $8K in Q3 2014.
  • 107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2021.

Based on Next Financial Group's 13F filing for Q3 2021, filed 15 Oct 2021.